AI English summary of an SEC filing — figures as filed
Zimmer Biomet ZBHZimmer Biomet said on November 13, 2024 that it entered into an underwriting agreement with Barclays Bank PLC, Goldman Sachs & Co. LLC, HSBC Bank plc and RBC Europe Limited as representatives of the underwriters. The agreement covers the public offering of €700.0 million aggregate principal amount of 3.518% notes due 2032.
Key points
AI summaryZimmer Biomet said on November 13, 2024 that it entered into an underwriting agreement with Barclays Bank PLC, Goldman Sachs & Co. LLC, HSBC Bank plc and RBC Europe Limited as representatives of the underwriters. The agreement covers the public offering of €700.0 million aggregate principal amount of 3.518% notes due 2032.
The company said the sale of the notes is scheduled to close on November 20, 2024, subject to customary closing conditions. It said the agreement contains representations, warranties, covenants and conditions customary for transactions of this type, and that the company agreed to indemnify the underwriters against certain liabilities on customary terms.
The company said the notes bear interest at 3.518% per annum, payable annually in arrears on December December 15 of each year starting on December 15, 2025. It said the notes will mature on December 15, 2032. The notes will be issued under an eleventh supplemental indenture dated as of November 20, 2024.
The company said that if net proceeds of the offering are used to repay a portion of its $850.0 million aggregate principal amount of 1.450% notes due 2024 at maturity, underwriters and their affiliates that own those notes would receive their proportionate share of the net proceeds.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Zimmer Biomet €700.0 million 3.518% Notes Due 2032 Underwriting Agreement
Zimmer Biomet said on November 13, 2024 that it entered into an underwriting agreement with Barclays Bank PLC, Goldman Sachs & Co. LLC, HSBC Bank plc and RBC Europe Limited as representatives of the underwriters. The agreement covers the public offering of €700.0 million aggregate principal amount of 3.518% notes due 2032.
Source · Based on the filing body and exhibits
Expected Closing Date and Conditions of Note Issuance
The company said the sale of the notes is scheduled to close on November 20, 2024, subject to customary closing conditions. It said the agreement contains representations, warranties, covenants and conditions customary for transactions of this type, and that the company agreed to indemnify the underwriters against certain liabilities on customary terms.
Source · Based on the filing body and exhibits
Note Interest Rate, Payment Dates and Maturity
The company said the notes bear interest at 3.518% per annum, payable annually in arrears on December December 15 of each year starting on December 15, 2025. It said the notes will mature on December 15, 2032. The notes will be issued under an eleventh supplemental indenture dated as of November 20, 2024.
Source · Based on the filing body and exhibits
Use of Proceeds Related to 2024 Notes Repayment
The company said that if net proceeds of the offering are used to repay a portion of its $850.0 million aggregate principal amount of 1.450% notes due 2024 at maturity, underwriters and their affiliates that own those notes would receive their proportionate share of the net proceeds.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…